R&D Sourcing Consultant
A collaborative leader with a balanced complement of R&D Procurement, Clinical Outsourcing, Business Development, Relationship Management and Drug Supply Management experience in the pharmaceutical industry, Scott has proven to be an invaluable resource to internal and external partners in collaborating with clinical leaders, and facilitating the commercial success of drug development and management efforts.
Scott currently works as an R&D Sourcing Consultant with Adare Pharmaceuticals supporting all of their R&D Sourcing work, providing strategic insights and advisory services to Adare’s phase IIb/III Eosinophilic Esophagitis (EOE) program.
Prior to joining Adare, Scott served as the Vice President of Business Development for Syneos Health (formerly INC Research/inVentiv Health) where he managed Top 20 Strategic Accounts, collaborated with the global Business Development team to develop strategies, and created the prioritization with ongoing clients and potential clients that present a partnership opportunity. Scott also obtained competitive intelligence and a comprehensive understanding of the client’s organization, portfolio, and sourcing strategy, in order to develop and/or grow partnerships with the prioritized key strategic clients. Scott lead entrepreneurial discussions with management team to development new and innovative ideas to build and maintain the Syneos Health enterprise. Scott also supported Executive & Operational Leadership on the interactions and governance with 3rd party suppliers and worked with 3rd party suppliers to develop and maintain innovative solutions consistent with the Syneos Health cross divisional brand.
Prior to joining Syneos Health, Scott served as Director / US Head, Outsourcing Management, for Clinical Outsourcing & R&D Procurement at Novartis Pharmaceuticals. Scott implemented cost controls via outsourcing agreements and was instrumental in developing and supporting the outsourcing strategies for the General Medicines franchises in Novartis. Under his direction, Scott led a team of 10 staff supporting six therapeutic areas and multiple line functions. Owing to his strong relationship cultivation and management skills, Scott ensured the global outsourcing management department was a relied upon resource for the rest of the organization. His work was critical to securing significant productivity savings through a supplier audit program. In support of clients’ requirements, Scott developed tools and process maps and created best practices to respond to changing needs of customers, including legal, operations, regulatory and finance.
Previously at Novartis, Scott served as Section Head, Central Laboratory & Diagnostic Services, Global CRO Management. during which time he served as a key member of the management leadership team. Scott led the implementation of category strategies to manage efforts and allocate work for central labs, cardiac safety and imaging. His work was instrumental in forming business alliances with central laboratory and diagnostic service preferred providers. Scott established master service agreements and negotiated rates to achieve cost savings. In an earlier role as Associate Director, Global CRO Management, Scott managed the strategic direction of outsourced central laboratory activities for Global Clinical Development & Medical Affairs.
For three years before joining Novartis, Scott was Manager, Global Outsourcing Management for Aventis Pharmaceuticals, Inc. In addition to overseeing the lifecycle of respiratory and cardiovascular assets, which included negotiating contract terms and monitoring spending, Scott supported clinical teams though lifecycle asset management. He negotiated master service agreements with clinical research organizations across several disciplines.
Scott commenced his pharma career with Covance, Inc. where he was twice promoted before joining Rhone-Poulenc Rorer, Inc. as Clinical Supplies Liaison.
Scott received numerous Novartis awards, including a BRAVO Award for outstanding contributions; multiple Above & Beyond awards; a Business Excellence Award; and the Pharma Development Award – Inspired Development Team.
Scott completed his Master of Arts in Organization Development from Temple University and his Bachelor of Arts in Speech Communications from York College of Pennsylvania.
This session will cover the following in reviewing Large Pharma vs. Small Pharma From a Sourcing Perspective: Lessons learned from a sourcing perspective Differences between large pharma vs. small pharma Leveraging strengths and mitigating weaknesses of large pharma vs. small pharma Unique strategies to help you succeed in both